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ACETOACETATE ENHANCES OXIDATIVE METABOLISM AND 
RESPONSE to TOXICANTS of CULTURED RENAL CELLS 
Trudi Denoon 
In vitro methods can be cost effective and facilitate large scale drug screening 
in the pharmaceutical industry. Renal proximal tubular cells have been a prime target 
for drug induced toxicity. LLC-PK1 cells possess many transport functions of the 
proximal tubule epithelia, however, its energy metabolism differs from the highly 
oxidative tubule metabolism in vivo. This may impact its reliability in predicting 
toxicity. Modulating the growth media composition has been shown to shift cultured 
liver and muscle cells from high glycolytic activity to increased oxidative 
metabolism, but few studies have been done on renal cells.  
This study is designed to test the impact of growth media modulation on 
mitochondrial respiration and glycolytic activity of LLC-PK1 cells via measurement 
of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) using 
the Seahorse XFp Analyzer (Agilent Technologies). Cells were grown to confluence 
in SFFD (50:50 DMEM-Ham’s nutrient mix F-12 with 15 mM HEPES) culture 
medium containing 3% FBS and 5mM glucose or 5mM glucose supplemented with 
5mM acetoacetate. Extracellular flux (XF) analysis showed that the basal respiration, 
maximal respiration, spare respiratory capacity and ATP-linked respiration were 
significantly increased, indicating an increase in mitochondrial function. The increase 




 of mitochondrial biogenesis, PGC-1α and TFAM. There was also an increase 
in mitochondrial COX IV expression. Additionally, XF analysis also showed a 
significant decrease in glycolytic capacity and reserve for the acetoacetate group. 
LC50 values for mitochondrial toxicants, clotrimazole, diclofenac and 
ciprofibrate were assessed via a modified trypan blue staining assay. Cells grown in 
media complemented with acetoacetate displayed significantly lower LC50 values 
when treated with clotrimazole and diclofenac. There was a marked increase in 
uncoupled respiration in the presence of diclofenac, while clotrimazole and 
ciprofibrate significantly decreased respiration in the acetoacetate group. In 
conclusion, acetoacetate complemented media can alter the cellular metabolism of the 
LLC-PK1 cell line and increase its sensitization to toxicants, thus making this a better 
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The drug development process can consist of three parts namely, drug 
discovery, preclinical development and clinical trial (Steinmetz and Spack 2009). Pre-
clinical research is an important step in the drug development process. It is necessary 
for researchers to assess potential new drugs for toxicity before progressing to the 
clinical research phase of the new development process. Preclinical studies will assess 
efficacy, explore pharmacology and utilize toxicology-based assays that establish 
dose, route and frequency that will be used in subsequent studies (Steinmetz and 
Spack 2009). The studies are usually designed to assess absorption, distribution, 
metabolism and excretion (ADME) and bioavailability parameters of the new drug 
(Steinmetz and Spack 2009).  For this reason, current pre-clinical development is 
dependent on in vitro and in vivo studies. 
Pharmaceutical xenobiotics intended to be therapeutics can have deleterious 
effects on mitochondrial function (Will and Dykens 2014). Most of these side effects, 
such as electron transport chain (ETC) inhibition and uncoupling of ATP production 
are not always detected by the preclinical cell-based and animal studies (Will and 
Dykens 2014). Toxicity often remains undetected until large numbers of patients have 
been exposed (Will and Dykens 2007). Mitochondrial impairment typically affects 
the most aerobically poised tissues, such as kidney and heart, or tissues exposed to 
higher concentrations of the drug, such as the liver (Will and Dykens 2007). 
Pharmaceuticals such as cerivastatin, have been withdrawn from the market due to 







 A major disadvantage of currently used immortalized in vitro models is that 
they are less sensitive than primary renal tubular cells to nephrotoxicants (Li et al. 
2013). Primary cells in culture can be used for toxicity testing given their metabolic 
activity (Marroquin et al. 2007). Yet the difficulties with isolation and brief survival 
rate can increase the cost of maintenance and limit their utility. Although 
immortalized cell lines are cheaper alternatives, studies have highlighted that most 
drugs fail at the clinical testing phase due to poor predictability during in vitro testing 
(Li et al. 2013). A study designed to evaluate the Environmental Protection Agency 
(EPA) ToxCast catalog of chemicals, conducted a high-throughput screening assay of 
compounds with mitochondrial liabilities (Wills et al. 2015).  Rabbit primary renal 
proximal tubular cell (RPTC) and was exposed to 676 compounds from the ToxCast 
catalog. RPTC identified 486 of these compounds as ETC inhibitors. A third of these 
compounds (131) were exposed to the immortal cell line human kidney 2 (HK2). This 
cell line only identified 14 compounds as ETC inhibitors (Wills et al. 2015). This 
indicates that there is a reduced sensitivity and low predictability in immortal renal 
cell lines. 
A possible solution would require the use of cells lines that have improved 
sensitivity, eliminating some of the pitfalls that commonly plague cells in culture. 
Immortalized and/or tumor derived cell lines are adapted to grow rapidly under 
hypoxic and acidic conditions as they meet their energy requirements via glycolysis 
(Marroquin et al. 2007). These cells are usually cultured in high glucose 
concentration such as 25 mM resulting in the Crabtree effect, which is the glucose 






fructose 1,6 bisphosphate (Marroquin et al. 2007). There is glucose induced 
stimulation of hexokinase and phosphofructokinase-1 activity, resulting in an increase 
in fructose 1,6 bisphosphate (Rodriguez-Enriquez et al. 2001). Fructose 1,6 
bisphosphate can activate pyruvate kinase, which irreversibly catalyzes the second 
glycolytic reaction that generates ATP (Marroquin et al. 2007).  Thus, there is an 
overall increase in the glycolytic flux with a concomitant decrease in oxidative 
metabolism as pyruvate the terminal product in glycolysis, is converted to lactate. 
Under these conditions, most cells derive most of their ATP from glycolysis, not from 
oxidative phosphorylation (Will and Dykens 2014). Cells cultured in this manner will 
be less sensitive to mitochondrial toxicants and limit their utility as predictors of 
adverse effects and toxicity of mitochondrial drug/compounds (Marroquin et al. 
2007).  
The human immortalized cell lines that do not accurately report mitochondrial 
liabilities can result in huge costs to the pharmaceutical industry with hepatoxic, 
cardiotoxic and nephrotoxic effects. Kidneys are organs that are susceptible to 
mitochondrial toxicants, due to drug metabolism (biotransformation) and high energy 
demand. Kidney cell lines such as human kidney cell line 2 (HK-2) have high rates of 
glycolytic activity and do not accurately screen for mitochondrial toxicants (Wills et 
al. 2015). Altering growth media composition with different substrates has been 
shown to shift cultured liver and muscle cells from high glycolytic activity to 
increased oxidative metabolism, but few studies have been done on renal cells. Thus, 
media modulation might reprogram the cell lines routinely used in toxicity testing and 








Kidney structure, function and metabolism 
 
The kidneys regulate body fluid volume, secrete hormones, and excrete waste 
products and xenobiotics (Stallons et al. 2013). Renal epithelial cells meet most of 
their energy demands through oxidative metabolism and are susceptible to injury 
from mitochondrial toxicants (Stallons et al. 2013).  Ninety percent of drug induced 
kidney injury takes place within the proximal tubule due to their elevated metabolic 
activity, increased number of transporters, higher blood flow and greater oxygen 
tensions (Bonventre et al. 2010).  
 Blood plasma is filtered by the glomerulus and moves into the proximal 
tubule. The processing of the filtrate helps to eliminate waste while regulating fluid, 
electrolyte and acid-base balance (Bonventre et al. 2010). The proximal tubular cells 
are sensitive to drug induced toxicity due to its role in concentrating the glomerular 
filtrate. Nephrotoxicants in the filtrate can be concentrated fivefold in the proximal 
tubules (Bonventre et al 2010). Most xenobiotics are removed from circulation via 
transporter-mediated secretion which primarily occurs in the proximal tubules 
(George et al. 2017).  
Transporters that line the tubules are necessary for the regulation of the fluid 
and utilize substantial amounts of energy. As a result, the proximal tubules are rich in 
mitochondria and meet their energy demands via oxidative phosphorylation 
(Norbakhsh and Singh, 2014). A major task of proximal tubular cells is the active 






solutes and water (Gstraunthaler et al. 1999). Approximately 80% of oxygen 
consumed for ATP production supports active sodium transport, while 15-20% 
accounts for basal metabolic activity (Nourbakhsh and Singh, 2014). In the kidney, 
the rate of respiration linearly follows the rate of active transport (Mandel 1986). 
About 70% of proximal tubular cell oxygen consumption is metabolically used to fuel 
Na+/K+-ATPase activity (Gstraunthaler et al. 1999). Increase in Na+/K+-ATPase 
activity increases the demand for ATP, resulting in an increase in respiration (Mandel 
1986).  
Oxidative phosphorylation is an energy pathway that can provide enough ATP 
to support the rate of active transport in the kidney. Oxidative phosphorylation can 
yield 38 molecules of ATP from one molecule of glucose whereas glycolysis can 
yield 2 net molecules of ATP from one molecule of glucose (Nourbakhsh and Singh, 
2014). Therefore, oxidative metabolism can meet the energy demands of the kidney. 
These chemicals are then cleared from the tubular cells by transporters on the 
apical/tubular membrane and added to the filtrate (George et al. 2017).  
 However, some compounds are reabsorbed by the apical transporters which 
increases the net intracellular concentrations of drugs and xenobiotics resulting in 
deleterious effects. Additionally, basolateral uptake from the peritubular capillaries 
can also increase the intracellular concentrations of toxicants (Bonventre et al. 2010). 
The excretion of the herbicide paraquat provides a demonstrable example of transport 
induced tubular injury.  The kidneys are responsible for eliminating the majority of 
paraquat is absorbed into systemic circulation (George at al. 2017). In vitro transport 






cation transporter 2 (OCT2), mediated the uptake of paraquat from the blood and is 
responsible for its intracellular accumulation (George et al. 2017). Paraquat 
participates in redox cycling that produces in superoxide formation, resulting in 
tubular degeneration and necrosis (George et al. 2017) 
The tubules contain drug metabolizing enzymes that participate in 
biotransformation, which can potentiate the toxicity to tubular cells (Bonventre et al. 
2010). Cytochrome P450 enzymes and the enzymes of conjugation are found mainly 
in the cortex, the location for the proximal tubule (Lohr et al. 1998). The drug 
metabolizing enzymes alter the parent compounds, making them more polar. This 
facilitates excretion (Lohr et al. 1998). Amino acid conjugation results in loss of 
pharmacological activity for some compounds. This increases the probability of 
excretion via tubular secretion methods (Lohr et al. 1998).  
Glycine conjugation increases the polarity of benzoic and salicylic acid which 
facilitates their excretion (Lohr et al. 1998).  
Biotransformation can result in conversion of parent compounds to toxic 
metabolites that can accumulate in the intracellular regions of the tubular cells. The 
high mitochondrial density cells that line the tubules, make proximal tubular cells and 
by extension the kidney susceptible to mitochondrial toxicants (Lohr et al. 1998). 
Beta lactam antibiotics such as cephaloridine, were shown to accumulate in rat 
proximal tubular cells via interaction with the apical basolateral organic anion 
transporter 3 (OAT 3) (George et al. 2017). 
An in depth look at energy metabolism in the kidney, indicates that glucose is 






taken to contribute 50-80% of the fuel of respiration of the kidney (Weidemann and 
Krebs 1969). In cortical slices of male rats, 5 mM glucose contributed 30.3% to the 
respiratory fuel and only 11.3% after starvation (Weidemann and Krebs 1969). 
Acetoacetate (5 mM) or butyrate (10 mM) provided up to 80%, in comparison to 
oleate (2 mM) which provided up to 50% of the fuel of respiration in male rate 
cortical slices (Weidemann and Krebs 1969). Therefore, glucose provided the lowest 
contribution the respiratory fuel, suggesting that it is not the preferred substrate in 
vivo. Fatty acid and ketone body metabolism takes place in the mitochondria. Given 
the high mitochondrial density of the proximal tubular cells, the above-mentioned 
substrates are better sources of energy for the kidney. 
Thus, the kidney is an organ that is extremely sensitive to toxicants. However, 
its in vitro counterparts do not reflect the in vivo findings. Current pre-clinical in vitro 
toxicity contributes to drug attrition during pre-clinical studies and phase 3 (Li et al. 
2013). Models used in pre-clinical testing have low predictability due to the reduced 
sensitivity resulting in the late detection of renal toxicity. One reason there is 
decreased sensitivity is the increased dependence on glycolysis to meet energy 
demands. (Wills et al. 2015). Thus, there is a need for an improved model that reflects 
the activity often seen in vivo. 
 
In vitro models: toxicity screening 
Current methods in pre-clinical development utilize both in vitro and in vivo 
testing platforms (Steinmetz and Spack, 2009).  However, there is the desire to reduce 






culture systems are a cost-effective method that facilitates drug toxicity identification 
in organ systems (Li et al. 2003). In vitro models can facilitate the identification of 
mechanisms of drug induced toxicity that are often complicated by multi organ 
systems present in the in vivo model (Davila et al. 1998).  It has been shown that 
many drugs target renal proximal tubular cells. These cells are sensitive to many 
chemical agents and serves as a prime target for drug induced toxicity. (Li et al. 
2003). Renal proximal tubular cells are responsible for excreting many metabolites, 
xenobiotics and drugs (Li et al. 2003). Thus, continuous cell lines as well as primary 
cultures are powerful tools for studying the biochemical and physiological 
characteristics of renal proximal tubular cells (Gstraunthaler et al. 1999). Renal 
tubular cells isolated from humans and animals can be used successfully to assess the 
physiological roles of the kidney (Li et al. 2003).   
Human primary cells are difficult to obtain in substantial amounts and even 
more difficult to maintain. As a result, continuous or immortal cell lines can be a 
suitable alternative. The human kidney cell line 2 (HK-2), and the human embryonic 
kidney 293 (HEK293, HEK-293, or HEK) cells are human proximal tubular cell lines 
that are routinely used for in vitro toxicity testing. Current human kidney cell lines 
have been transfected with viral genes to make them immortal (Heussner and Dietrich 
2013). HK-2 cells have been transfected with HPV virus, while the HEK 293 cells 
have been transfected with the adenovirus 5 (Heussner and Dietrich 2013). 
Additionally, immortalized cell lines are metabolically adapted for rapid growth and 






cells are typically grown in 25 mM glucose (450 mg/dL), fivefold higher than the 
physiological level (90 mg/dL) (Marroquin et al. 2007).  
 
An article published by Lauren Willis and co-workers in April 2015, 
demonstrated that immortalized cell lines may not fully detect mitochondrial 
toxicants. 19 compounds were identified as cytotoxicants in rabbit primary renal 
proximal tubular cells (RPTC). However, 15 had no effect on viability in HK-2 cells 
(Wills et al. 2015).  HK-2 cells are cultured in Roswell Park Memorial Institute 1640 
Medium (RPMI) and  consists of 10 mM glucose and 10 % FBS (Wills et al. 2015). 
Additionally, HK-2 cells do demonstrate dome formation, a hallmark of active 
sodium transport and an important feature of proximal tubular cells.  
 Porcine kidney cells can be used as an alternative to human cell lines. The 
porcine kidney shares anatomical and physiological features with that of human 
kidney and is relatively accessible (Heussner and Dietrich 2013). Fully sequenced 
porcine transporters (Oat1 and 3) demonstrate higher structural/amino acid identity to 
the human homologues when compared to those of either mice or rats. (Heussner and 
Dietrich 2013). Therefore, a porcine renal in vitro model can be a cheaper model that 
is easier to maintain than its human counterparts. 
The LLC PK-1 cells are derived from the Hampshire pig (Lohr et al. 1998). 
The LLC PK-1 cell line has been one of the most characterized lines that has not been 
malignantly transformed unlike the HK-2 and HEK 293 cells. It is an established cell 






developed by the Eli Lilly Company. Hull and co-workers indicated that LLC-PK1 
cells retain many properties and functions that are characteristic of tubular cells 
belonging to normal porcine kidneys.  LLC-PK1 cells have retained characteristic in 
vivo ion and solute transport (sodium transport and activity of Na, K-ATPase) as 
evidenced by dome formation (Felder et al. 2002). Domes are formed by cells that 
detach themselves from the substratum, owing to the buildup of pressure on the 
basolateral side of the monolayer due to transepithelial transport of salt and water and 
the potency of the tight junctions in making the monolayer impermeable to fluid. This 
dome formation results from the monolayer formed by the cells in culture (Hull et al. 
1976).  
Although cultured renal porcine proximal tubule cells maintain many of their 
in vivo characteristics, it has been demonstrated that these cells dedifferentiate from 
an oxidative metabolism to high rates of glycolysis. This is highly uncharacteristic of 
proximal tubular cells and is typically not seen in vivo (Felder et al. 2002). The most 
prominent observable changes are the decline in enzymes associated with oxidative 
metabolism coupled with an increase in glycolysis (Gstraunthaler et al. 1999). LLC-
PK1 cells demonstrated a decline in apical microvilli and mitochondrial volume. 
These changes were accompanied by an increase in glycolytic enzymes such as 
hexokinase (HK), phosphofructokinase (PFK), pyruvate kinase (PK) and lactate 
dehydrogenase (LDH) (Gstraunthaler et al. 1999).  
There are several reasons that can contribute to this observable characteristic. 
Reduced oxygenation of the cultured cells has been indicated as one reason for the 






supplementation and shaking media culture conditions to increase oxygen supply and 
improve oxidative metabolism in RPTC (Nowak and Schnellman 1995). In 
Gstraunthaler et al. (1999), a roller bottle method was utilized to improve 
oxygenation of epithelial monolayers. LLC-PK1 cells were cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM) with low glucose (5.5 mM), and grown on the 
wall of cylindrical bottle that turned at 60 rev/hr. The combination of low glucose and 
increased oxygenation significantly decreased expression of glycolytic enzymes HK, 
PFK and LDH (Gsthraunthaler et al. 1999).   
Immortalized and/or tumor derived cell lines are adapted to grow rapidly and 
exhibit abnormal energy metabolism when they are grown in standard cell culture 
conditions in the presence of media containing high concentrations of glucose 
(Nowak and Schnellman 1995). High glucose concentrations such as 25mM can 
induce the Crabtree effect, which is the glucose mediated inhibition of oxidative 
phosphorylation (Diaz-Ruiz et al. 2008). Phosphofructokinase (PFK), a regulatory 
enzyme for glycolysis, showed a steady increase in activity in LLC-PK1 when 
glucose concentrations increased from 1.85 to 5.5 mM (Gstraunthaler et al. 1999). 
This indicates that increasing concentrations of glucose will stimulate glycolytic 
activity. 
The Crabtree effect is described as a reversible switch between glycolysis and 
oxidative metabolism that is dependent on the presence of glucose (Diaz-Ruiz et al. 
2008). This differs from the Warburg effect, which is the suppression of oxidative 
metabolism in the presence of sufficient oxygen content. It was originally believed 






this has since been refuted (Diaz-Ruiz et al. 2008). If LLC-PK1 cells are displaying 
the Crabtree effect, then it would be possible to metabolically reprogram them by 
reducing the glucose concentration and/or improving the media content. 
An article published by Weidemann and Krebs (1969), demonstrated that 
added acetoacetate and butyrate provided 80% of respiratory fuel for kidney cortex 
slices of male rats. Added glucose (5 mM) only provided 25-30% of the respiratory 
fuel (Weidmann and Kreb 1969). Some parts of the nephron such as the thick 
ascending limb of the loop of Henle, use glucose as its metabolic substrate. However, 
there is a reduced rate of respiration in proximal tubules when glucose is the only 
exogenous substrate (Mandel 1986).  
What is of more importance is their ability to compensate for mitochondrial 
dysfunction by utilizing glycolysis for ATP generation. Hence, these cultured cells 
are more resistant to mitochondrial toxicities. Immortalized cell lines that are widely 
used for in vitro toxicity testing have evolved to grow and survive in hypoxic 
environments and fulfill their energy requirements via glycolysis instead of oxidative 
phosphorylation. Thus, many mitochondrial toxicants fail to impact mitochondrial 
function and cell viability in such cell lines because of this adaptation (Wills et al. 
2015).  
Complemented Media and Oxidative metabolism 
Mitochondrial toxicity often serves as the primary mechanism of toxicity for 
most consumer products such as pesticides and pharmaceuticals (Wills 2017). 






active transport of sodium. This feature makes the kidney especially sensitive to 
mitochondrial toxicants. Therefore, it is important to utilize an in vitro model that 
relies on oxidative phosphorylation to increase predictability.  
One method of achieving this outcome is to modify the energy substrate 
content of the growth media. In vitro culture models, including LLC PK1, are cultured 
in media that contain glucose as the main carbon source of energy. Addition of 
glucose to culture media of ascite AS-30D hepatoma cells lowered the pH, stimulated 
an increase in glycolytic enzymes and led to an inhibition of oxidative 
phosphorylation (Rodriguez-Enriquez et al. 2001). This suggests that current culture 
conditions where glucose is the main substrate will stimulate an increase in glycolytic 
activity with a concomitant decrease in mitochondrial respiration.  HEPG2 cells 
cultured in DMEM with 25 mM glucose tolerated up to 1 μM of Rotenone without 
significant loss in viability (Marroquin et al. 2007). LLC-PK1 cells showed an 
increase in glycolytic enzymes when glucose concentrations increased to 25 mM 
(Gstraunthaler et al. 1999).  
Media modulation has been shown to improve oxidative metabolism of 
primary proximal tubular cells. In a study by Nowak and Schnellmann (1996), 
primary rabbit proximal tubular cells were cultured in medium that consisted of 50:50 
mixture of DMEM and Ham’s F-12, 5.5 mM glucose and 50 μM ascorbate-2-
phosphate. The combination of low glucose (5.5 mM) and ascorbate stimulated an 
increase in basal oxygen consumption by 39% when compared to cells cultured in 5 






Media modulation has also been effective in metabolically reprogramming 
immortalized liver and skeletal muscle cells. Oleic acid (albumin conjugate) in the 
presence of 5 mM glucose, increased oxidative metabolism by stimulating an increase 
in the genes associated with fatty acid oxidation (Lim et al. 2013). Hepa 1.6 liver 
cells, grown in DMEM complemented with 5.5 mM glucose and 30 μM oleic acid 
were able to increase mitochondrial bioenergetic activity (Andreux et al. 2014). Fatty 
acid complemented media can represent a viable option as fatty acid beta- oxidation, 
takes place in the mitochondria and will utilize oxidative pathways to generate ATP. 
Previous work in our lab made attempts to culture LLC PK1 cells in growth media 
complemented with oleic acid. However, oleic acid did not significantly alter the 
mitochondrial or glycolytic function. Thus, fatty acid complemented media were 
ineffective at reducing glycolysis and stimulating oxidative metabolism in LLC-PK1 
cells. 
Complementing culture media with other energy sources can increase 
oxidative metabolism. Galactose has been used to improve the mitochondrial 
respiration of liver cells.  Hep G2 liver cells cultured in DMEM complemented with 
10 mM galactose and no glucose stimulated an increase in basal respiration rates 
compared to cells in 25 mM glucose (Marroquin et al. 2008). Previous work in our 
lab utilized galactose complemented media. When LLC-PK1 cells were cultured in 
the presence of 10 mM and 5 mM galactose +/- glucose, the morphology changed and 






Ketone bodies can be used as a source of energy and has been shown to 
metabolically reprogram pancreatic cell lines and tumors (Shukla et al.2014). Sodium 
3-hydroxybutyrate reduced glucose uptake as well as a decreased expression of 
glycolytic enzymes (Shukla et al. 2014). Treatment of the S2-013 human pancreatic 
cell line with 20 mM sodium-3-hydroxybutyrate shifted the bioenergetics of this line 
by reducing the glycolytic flux. (Shukla et al.2014). Treatment with this ketone body 
also reduced glucose uptake by reducing the expression of the glucose transporter 1 
(GLUT 1) (Shukla et al. 2014). Additionally, beta-hydroxybutyrate also reduced 
lactate secretion by reducing expression of the lactate dehydrogenase A (LDHA), a 
subunit of the lactate dehydrogenase enzyme. (Shukla et al. 2014). Previous studies in 
our lab evaluated the impact of 5 mM betahydroxybutyrate (BHB) complemented 
media on the mitochondrial function of LLC-PK1 cells. BHB did not significantly 
increase mitochondrial function when compared to LLC-PK1 cells grown in 5 mM 
glucose or 5 mM acetoacetate. 
Additional compounds were assessed for potential impact on mitochondrial 
function.  Previous studies done in our lab evaluated quercetin for its protective effect 
on epithelial to mesenchymal transition (EMT). Quercetin is a phenolic flavonoid, 
found in many fruits, that has antioxidant properties (Rayamajhi et al. 2013). 
Quercetin has been shown to improve mitochondrial function and stimulate 
mitochondrial biogenesis. Primary mouse hepatocytes treated with varying doses of 
quercetin for 24 hours showed an increase in mitochondrial function and oxidative 
metabolism (Kim et al. 2015). HEP G2 cells treated with 15 µM for 24 hours, 






expression (Rayamajhi et al. 2013). Quercetin induced mitochondrial biogenesis is 
accompanied by an increase in COX IV (Rayamajhi et al. 2013). Peroxisome 
proliferator-activated receptor-γ coactivator (PGC)-1α (PGC-1𝛼) is a master regulator 
of the transcriptional network that regulates mitochondrial biogenesis (Rayamajhi et 
al. 2013). PGC-1𝛼 activates mitochondrial transcription factor A (TFAM) that is 
responsible for transcribing proteins involved in mitochondrial DNA (mtDNA) 
transcription (Rayamajhi et al. 2013). Mitochondrial DNA encodes for subunits of the 
electron transport chain (Rayamajhi et al. 2013). Therefore, an increase in PGC-1𝛼 
expression stimulates an increase in TFAM expression which results in an increase in 
ETC subunits such as COX IV.  
Thus, there was a rationale to complementing the culture media with 
acetoacetate and quercetin to alter the bioenergetic activity of LLC PK1 cells. 
Metabolic reprogramming of this cell line will be examined via the assessment of 
mitochondrial and glycolytic function, mitochondrial content and sensitivity to 
mitochondrial toxicants. Given these findings we proposed that complementing 
culture media with ketone bodies will alter the bioenergetic activity of the LLC-PK1 
line resulting in an increase in oxidative metabolism 
Purpose of the study 
This study will determine if media complementation will alter energy 
metabolism of LLC-PK1 cells and increase the sensitivity to toxicants. 
Complementing the media with additional substrates may diminish the Crabtree 






preliminary studies were conducted, the results of which led to three formal 
hypotheses. To effectively study the impact of low glucose concentration on 
mitochondrial and glycolytic parameters, glucose concentration was lowered from 
17.5 mM to 5 mM and the mitochondrial and glycolytic function was assessed via 
extracellular flux analysis (Seahorse Agilent TM). To evaluate the effect of media 
modulation on the metabolism of LLC-PK1 cells, culture media were complemented 
with 5mM or 2 mM glucose in the presence or absence of acetoacetate or quercetin. 
Mitochondrial function was assessed via extracellular flux analysis. The results of the 




Acetoacetate complemented culture media stimulates metabolic 
reprogramming of LLC-PK1 cells by increasing mitochondrial function with a 
compensatory decrease in glycolytic function.  
To adequately test this hypothesis, there were two specific aims: 
1. To determine via extracellular flux analysis whether supplementation 
with 5 mM acetoacetate in the presence of 5 mM glucose affects the 
mitochondrial activity of LLC-PK1 cells.  
2. To examine via extracellular flux analysis whether complementation 
with 5 mM acetoacetate in the presence of 5 mM glucose affects the 







 Acetoacetate in the presence of 5 mM glucose stimulates an increase in 
mitochondrial content.  
To adequately test this hypothesis, there was one specific aim: 
1. To Determine whether acetoacetate stimulates an increase in markers 
of mitochondrial biogenesis and content. 
 
Third hypothesis 
5 mM acetoacetate in the presence of 5 mM glucose will sensitize LLC-PK1 
cells to mitochondrial toxicants. 
 To adequately test this hypothesis, there were two specific aims: 
1. To examine if acetoacetate supplementation alters the LC50 value of 
mitochondrial toxicants.  
2. To evaluate if mitochondrial function of  LLC-PK1 cells cultured in 
acetoacetate complemented media are affected by mitochondrial 
toxicants.  
 
Mitochondrial and Glycolytic assessment 
Extracellular flux analysis detects small changes in the cell bioenergetics in 
real time by measuring changes in the oxygen consumption rate (OCR) and the 
extracellular acidification rate (ECAR). OCR measurements represent mitochondrial 
function by assessing the activity of the electron transport chain (ETC). ECAR 
measurements give a representation of glycolytic function. Mitochondrial function 






maximal respiration, ATP-linked respiration and spare respiratory capacity (figure 
1). This tool will be used to extensively in this study to evaluate the effect of 
complemented media on bioenergetics. Basal respiration is the energetic demand of 
cell under baseline conditions, controlled by ATP turnover, substrate oxidation and 
proton leak (Brand and Nicholls 2011). 
 Maximal respiration is the maximal respiration rate in the presence of an 
uncoupler eg carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP), which 
stimulates respiratory chain to operate at maximum capacity (Brand and Nicholls 
2011).  ATP-linked respiration is the rate of mitochondrial ATP synthesis under basal 
state/conditions. It represents the portion of basal respiration used to drive ATP 
synthesis (Brand and Nicholls 2011). Spare respiratory capacity is the ability of 
substrate supply and electron transport to respond to an increase in energy demand. It 
is the capability of the cell to respond to an energetic demand (Brand and Nicholls 
2011). 
 Glycolytic function will be assessed by measuring the glycolytic parameters 
glycolysis, glycolytic capacity and glycolytic reserve (figure 2). In the flux analysis 
assay, Glycolysis is defined as the acidification rate that results from the addition of 
25 mM glucose. This is the measure of the conversion rate of glucose to pyruvate or 
lactate (Mookerjee et al. 2016). Glycolytic capacity is the measurement is the 
maximum extracellular acidification rate reached by a cell following the addition of 
oligomycin, an ATP synthase inhibitor.  This shuts down oxidative phosphorylation 
and driving the cell to use glycolysis to its maximum capacity (Mookerjee at al. 






demand as well as how close the glycolytic function is to the cell’s theoretical 



















Basal Respiration Energetic demand of cell under baseline 
conditions, controlled by ATP turnover, 
substrate oxidation and proton leak 
Maximal Respiration Maximum respiration rate in the 
presence of an uncoupler. Stimulates 
respiratory chain to operate at 
maximum capacity 
ATP linked respiration Rate of mitochondrial ATP synthesis 
under basal state/conditions. The 
portion of basal respiration used to 
drive ATP synthesis 
Spare Respiratory Capacity The ability of the substrate supply and 
electron transport chain to respond to an 
increase in energy demand. The ability 
of the cell to respond to an increase in 
energetic demand 
Table 1: Measured mitochondrial parameters 
Compound Effect 
Oligomycin ATP Synthase/Complex V inhibitor. 
Useful to determine fraction of OCR 
used for ATP production 
FCCP (carbonilcyanide p-
triflouromethoxyphenylhydrazone ) 
Uncoupler. Used to calculate maximal 
respiration and spare capacity 
Rotenone Complex I inhibitor. Shuts down the 
electron transport chain (ETC) to 






Antimycin A Complex III inhibitor. Necessary for 
shutting down the ETC to calculate non-
mitochondrial respiration 
Table 2: Mito Stress Test protocol  
 
Glycolytic Assessment 
















Glycolysis Acidification rate that results from the 
addition of 25 mM glucose. Measure of 
the conversion rate of glucose to 
pyruvate or lactate 
Glycolytic Capacity This measurement is the maximum 
ECAR reached by a cell following the 
addition of oligomycin, effectively 
shutting down oxidative 
phosphorylation and driving the cell to 
use glycolysis to its maximum capacity 
Glycolytic Reserve This measure indicates the capability of 
a cell to respond to an energetic demand 
as well as how close the glycolytic 
function is to the cell’s theoretical 
maximum 
Table 3: Measured glycolytic parameters 
 
Compound Effect 
Glucose Added after glucose starvation. 
Stimulates glycolysis 
Oligomycin ATP synthase/Complex V inhibitor. 
Stimulates an increased dependence on 







2-Deoxyglucose (2-DG) Inhibits glycolysis. Necessary to 
calculate non-mitochondrial 
acidification 
Table 4: Glyco Stress Test protocol  
 
 
2. MATERIALS AND METHODS 
Materials 
 Antimycin A (10189-312), FCCP (89156-962), oligomycin (80058-538), 
clotrimazole (AAJ63895-06), 96 well solid back flat bottom plates (29444-018) and 
Cayman MitoCheck® Citrate Synthase Activity assay (75817-190) were purchased 
from VWR. Trypan blue (0.4%) in PBS (Corning 25-900-CL), rotenone (361650), 
quercetin (50-498-664), lithium acetoacetate (A1478), and 2-deoxy glucose (11198-
0010) were purchased from Fisher. Diclofenac sodium salt (D6899-10G, 0.5% triton 
X-100 (Sigma T8787) and D-glucose (G0721-1KG) were purchased from Sigma 
Aldrich. All antibodies for western blotting PGC-1α (3G6) (rabbit mAb #2178), COX 
IV (3E11) (rabbit mAb #4850) and GAPDH (14C10) (Rabbit mAb #2118) were 
purchased from Cell Signaling. Western blot analysis conducted using the Simple 
Protein Wes separation assay module SM-W004, and the anti-rabbit detection module 
DM-001 was purchased from Protein Simple.  
 
Cell Culture 
LLC-PK1 clone 5 isolated by Dr. S. Ford in 1990 from the established cell line 
obtained from ATCC were grown on BD Falcon™ polystyrene tissue culture dishes 
(Thermo Fisher Scientific Cat# 353003) and maintained in the custom culture 






glucose. The growth medium was a custom formula based on 50:50 DMEM: Ham’s 
nutrient F12 with 15 mM HEPES, lacking phenol red (GIBCO custom formula, F# 
91-5173 EL). It was reconstituted with ultra-pure water and the appropriate 
components to pH 7.4 and the addition of 2.5 mM L-glutamine and 0.5 mM sodium 
pyruvate with 3% fetal bovine serum (FBS) (Hyclone Thermo Scientific; cat # 
SH30070.03).  
Antibiotics were not used.  The medium was complemented with the 
following: glucose (2 mM, 5 mM, or 17.5 mM), quercetin (15 µM), acetoacetate (5 
mM) or combinations of different substrates. The osmolality of the medium, +/- 
glucose, was 317 mOsm/kg.  Cells used in experiments were between passages 240 
and 260 and were maintained at 37ºC in an atmosphere of 95% air to 5% CO2. The 
medium in the tissue culture plate was changed every three days after inoculation and 
the cells were subcultured on the fourth day after inoculation. Subculturing was done 
by trypsinizing the cells with trypsin-EDTA (Gibco by Life Technologies; ref # 
15400-054) and split at a ratio of 1:5 or 1:10. The cultures were periodically checked 
for mycoplasma (Bionique Laboratories; Cat# M100). All experiments were carried 
out on confluent monolayers, determined by the presence of domes. 
Extracellular flux analysis  
LLC-PK1 cells were seeded into an 8 well extracellular flux mini culture plate 
(Agilent 103025-100) at a density of 8×104 cells/well and grown in the respective 
growth medium for 48 hours to achieve confluency. Cells were seeded into 6 of the 8 
wells, leaving the first and last well for background readings. The Mito Stress test or 






Mito stress test 
Growth medium was then removed, and the cells were washed twice with 200 
µL of Agilent XF base assay medium (102353-100) supplemented with either 17.5, 5, 
or 2 mM glucose, 2.5 mM glutamine and 0.5 mM sodium pyruvate. The medium was 
titrated with 0.2N of sodium hydroxide (NaOH) to adjust the pH to 7.4. 
 It was then filter sterilized and gently warmed until ready for use. A final 
volume of 180 µL was added to all 8 wells and the plate was then placed in a non- 
CO2 incubator. This was done at least 45 minutes before the start of the assay. XFp 
sensor cartridges (Agilent 103022-100) contain fluorophores that are quenched by 
oxygen and protons. These cartridges were soaked in the Seahorse XF calibrant 
solution (102353-100) the day before the assay and placed in a non-CO2 incubator. 
On the day of the assay a pre-soaked cartridge was loaded according the Mito Stress 
test protocol (Brand and Nicholls 2011) as follows: port A- 20 µL of 1 µM 
Oligomycin; port B- 22 µL of 1 µM FCCP; port C- 25 µL of 0.5 µM Antimycin A 
and 0.5 µM Rotenone mix. The oxygen consumption rate (OCR) and extracellular 
acidification rates were then recorded using the Seahorse Xfp analyzer (Agilent 
Technologies). The analyzer was switched on and warmed up 6 hours before the start 
of the assay. 
Glyco stress test 
The cells were seeded according to the previously mentioned method listed 
under extracellular flux analysis. Growth medium was then removed and the cells 
were washed twice with 200 µL of Agilent XF base assay medium (102353-100) 






to the Mito stress test protocol. The cells and cartridges were also prepared according 
to Mito Stress Test protocol. On the day of the assay, a pre-soaked sensor cartridge 
was loaded according the Glyco Stress test protocol (Mookerjee et al. 2016) as 
follows: port A- 20 µL of 25 mM glucose; port B- 22 µL of 1 µM oligomycin; port 
C- 25 µL of 50 mM 2-deoxyglucose. The extracellular acidification rates (ECAR) 
were then recorded using the Seahorse Xfp analyzer (Agilent Technologies).  
Mito stress test-Respirometric Analysis (acute effect of toxicants on mitochondrial 
function)  
LLC-PK1 cells were seeded into an 8 well extracellular flux mini culture plate 
(Agilent 103025-100) at a density of 8×104 cells/well and grown in the respective 
growth medium for 48 hours to achieve confluency. A Mito stress test was conducted, 
and cells were exposed to the determined LC50 values from the 24hr viability study. 
Compounds that inhibited the electron transport chain (clotrimazole and ciprofibrate), 
were added in the final port (port C) of the cartridge (figure 3). Given that diclofenac 
acts as an uncoupler (Moreno-Sanchez et al.1999), it was added to second port (port 
B) where it will uncouple respiration following exposure to oligomycin. To confirm 
its activity as an uncoupler, 1 µM of FCCP was added to port C to observe any 
impacts on OCR (figure 4). 
Extracellular flux data analysis and interpretation 
Both OCR and ECAR readings were interpreted using the Wave software 
(version 2.2.0). Once the plate is removed the cells are washed with PBS and then 
lysed with 140uL of 0.2N NaOH. The cell lysates will be placed into 1.7mL 






normalized to DNA content assessed using the AccuBlue® Broad Range DNA Assay 
kit. 10 µL of cell lysates were added to 96 well solid black microplates (Corning 
29444-018) followed by 200 µL of the AccuBlue® Broad Range working reagent. 
The working reagent contains 20 mL of the AccuBlue® Broad Range buffer followed 
by 200 µL of the AccuBlue® Broad range dye and 200 µL of the AccuBlue® Broad 
Range enhancer. Once sample and working reagent are added, the plate is placed in 
the dark for an incubation period of 10 minutes. Fluorescence is then measured using 
a microplate reader with 350 nm excitation/460 nm emission. 
Assessment of Citrate Synthase activity 
LLC-PK1 were seeded at a density of 5×10
6 cells/mL into T225 tissue culture 
flasks (Corning 353139). Once confluent (20×106 cells), culture media were removed, 
and the cells were washed twice with ice-cold PBS, scraped, and pelleted by micro 
centrifugation at 350 × g at 4ºC for 5 minutes. To obtain whole cell lysates, cell 
pellets were lysed using Radio-Immune Precipitation assay (RIPA) buffer containing 
protease and phosphatase inhibitors for 30 min on ice and centrifuged at 140000 × g 
at 4ºC. 5 µL of lysates containing 5 µg of protein was used for the assay and diluted 
with 995 μL of the assay buffer.  
The citrate synthase activity assay is a plate based colorimetric measurement 
in accordance with the Cayman MitoCheck® Citrate Synthase Activity Assay kit 
(701040). Citrate synthase activity is assessed via the formation of the tricarboxylate 
citrate that results from the condensation of oxaloacetate and acetyl CoA. The 
reaction is catalyzed by citrate synthase and yields SH-CoA. The product forms a 






Developing Reagent and measured at 412 nm. Absorbance is measured at 30 second 
intervals for 20 minutes. The results are graphed as the absorbance (y-axis) vs. time 
(minutes) (x-axis) and the slope of the linear portion of the curve is calculated. To 
determine the rate of reaction, the following equation is used:    
 
 
   
To determine the specific activity of the enzyme, the rate is divided by protein sample 
concentration (mg/mL).  
Mitochondrial biomarker protein expression 
LLC-PK1 cells were seeded into T225 tissue culture flasks (Corning 353139). 
Once confluent (20×106 cells), culture media were removed and the cells were 
washed twice with ice-cold PBS, scraped, and pelleted by micro centrifugation. To 
obtain whole cell lysates, cell pellets were lysed using Radio-Immune Precipitation 
assay (RIPA) buffer containing protease and phosphatase inhibitors for 30 min on ice 
and centrifuged at 140000 × g at 4ºC. Protein expression was quantified by using 
WES, an automated capillary-based system with immunodetection (Protein Simple, 
Bio-Techne, US) by following manufacturer's instructions. Samples, at a 
concentration of 1 mg/ml were subjected to capillary electrophoresis followed by 






receptor)-γ coactivator-1α] (PGC-1α), mitochondrial transcription factor A (TFAM), 
and cytochrome C oxidase (COX IV). Expression of protein of interest was 
normalized to expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).  
The optimized antibody dilutions were as follows: 
PGC-1α (1:100), TFAM (1:100), COX IV (1:100), and GAPDH (1:25000).  
 
Cell viability assessment 
Cell viability measured using a modified trypan blue-based viability assessment 
(Hammoudeh et al. 2019). Cells were seeded in 96 well plates at a density of 15 × 103 
cells/well and allowed to grow until confluent monolayers were formed.  
Cells were then treated for 24 hours with increasing concentrations of diclofenac (0.5 
- 5mM), clotrimazole (0.1 – 100 µM) and ciprofibrate (1 - 40 µM).  The treatment 
media were removed and the culture plate washed with PBS to remove dead cells, 
leaving only viable cells attached to the plate. The cells were first fixed with 4 % 
paraformaldehyde (Electron Microscopy Sciences 157-10) for twenty minutes, then 
permeabilized using 0.5% Triton X-100 (Sigma T8787) for 15 minutes. The cells 
were stained with 0.4% trypan blue in PBS (Corning 25-900-CL) for 30 minutes. 
Once staining was complete, the dye was removed, and cells were washed twice with 
PBS to remove any remaining trypan blue. The absorbance of the remaining viable 
cells was read at 530 nm.  Percent cell viability compared to controls was reported. 
The percent viability was plotted as % V.C. on the Y-axis and the concentration of 
the corresponding compound was plotted on the X-axis. Using this graph, the LC-50 






Statistical analysis  
Statistical analyses were conducted using the GraphPad Prism version 5 
(GraphPad Software, La Jolla CA, USA). For media complementation with varied 
nutrients and substrates, a one-way analysis of variance (ANOVA) was carried out 
using a Dunnett’s multiple comparison post-hoc analysis where all groups were 
compared to the selected control 5 mM glucose group. For cells cultured in 17.5 mM 
or 5 mM glucose as well as cells cultured in 5 mM glucose or 5 mM glucose + 5 mM 
acetoacetate, a student’s unpaired t-test was used to determine the significance of 
differences between two groups. Non-linear regression analysis was used to 
determine LC50 values. All data are represented as means ± SEM. Differences were 






























To examine the effect of lowering the glucose concentration on mitochondrial 
function, cells were cultured in 5 mM glucose or 17.5 mM glucose complemented 
medium. Mitochondrial function was assessed via the Seahorse Mito TM Stress Test 
and the oxygen consumption rates (OCR) were recorded using the Seahorse Xfp 
analyzer.  Lowering the glucose concentration from 17.5 mM to 5 mM, did not 
induce changes in any of the measured mitochondrial parameters. There was no 
change in basal respiration for cells grown in 5 mM and 17.5 mM glucose (figure 5). 
ATP-linked respiration (figure 6), maximal respiration (figure 3) and spare 
respiratory capacity (Figure 4) showed no significant differences between the two 
glucose groups.  
Cells cultured in 5 mM glucose or 17.5 mM glucose medium were assessed 
for glycolytic function via the Agilent-Seahorse Glyco TM Stress Test and the 
extracellular acidification rates (ECAR) were then recorded using the Seahorse Xfp 
analyzer (Agilent Technologies). Lowering the glucose concentration did not alter a 
change in the measured glycolytic parameters. There was no change in glycolysis 


















Figure 5. Basal respiration for LLC-PK1 cells grown in 5 mM and 17.5 mM 
glucose. LLC-PK1 cells were seeded into an 8 well extracellular flux mini culture 
plate (Agilent 103025-100) at a density of 8×104 cells/well and grown in 5 mM or 
17.5 mM growth medium for 48 hours to achieve confluency. The Agilent-Seahorse 
Mito Stress test protocol was then used and the oxygen consumption rates (OCR) 
were then recorded using the Seahorse Xfp analyzer and the results interpreted using 
the Wave 2.2.0 software.  Basal respiration was calculated as the (last rate 
measurement before oligomycin) - (non-mitochondrial respiration). Statistical 




























































Figure 6. ATP-linked respiration for LLC-PK1 cells grown in 5 mM and 17.5 
mM glucose. LLC-PK1 cells were seeded into an 8 well extracellular flux mini 
culture plate (Agilent 103025-100) at a density of 8×104 cells/well and grown in 5 
mM or 17.5 mM growth medium for 48 hours to achieve confluency. The Agilent-
Seahorse Mito Stress test protocol was selected and the oxygen consumption rates 
(OCR) were then recorded using the Seahorse Xfp analyzer and the results interpreted 
using the Wave 2.2.0 software. ATP-linked respiration was calculated as (last rate 
measurement before oligomycin injection)- (minimum rate measurement after 
oligomycin injection). Statistical significance was determined using Student’s 


























































Figure 7. Maximal respiration for LLC-PK1 cells grown in 5 mM and 17.5 mM 
glucose. LLC-PK1 cells were seeded into an 8 well extracellular flux mini culture 
plate (Agilent 103025-100) at a density of 8×104 cells/well and grown in 5 mM or 
17.5 mM growth medium for 48 hours to achieve confluency. The Agilent-Seahorse 
Mito Stress test protocol was selected, and the oxygen consumption rates (OCR) were 
then recorded using the Seahorse Xfp analyzer and the results interpreted using the 
Wave 2.2.0 software. Maximal respiration was calculated as (maximum rate 
measurement after FCCP injection) - (non-mitochondrial respiration). Statistical 



























































Figure 8. Spare Respiratory Capacity for LLC-PK1 cells grown in 5 mM and 
17.5 mM glucose. LLC-PK1 cells were seeded into an 8 well extracellular flux mini 
culture plate (Agilent 103025-100) at a density of 8×104 cells/well and grown in 5 
mM or 17.5 mM growth medium for 48 hours to achieve confluency. The Agilent-
Seahorse Mito Stress test protocol was selected, the oxygen consumption rates (OCR) 
were then recorded using the Seahorse Xfp analyzer and the results interpreted using 
the Wave 2.2.0 software. Spare respiratory capacity was calculated as (maximal 
respiration) - (basal respiration). Statistical significance was determined using 


























































Figure 9. Glycolysis for LLC-PK1 cells grown in 5 mM and 17.5 mM glucose. 
Cells cultured in 5 mM glucose or 17.5 mM glucose medium were assessed for 
glycolytic function via the Agilent-Seahorse Glyco TM stress test once cells achieved 
100% confluency, and the Glyco Stress test protocol was selected. The extracellular 
acidification rates (ECAR) were then recorded using the Seahorse Xfp analyzer 
(Agilent Technologies). Glycolysis was calculated as (maximum rate measurement 
before oligomycin injection) - (minimum rate measurement before glucose injection). 



















































Figure 10. Glycolytic Capacity for LLC-PK1 cells grown in 5 mM and 17.5 mM 
glucose. Cells cultured in 5 mM glucose or 17.5 mM glucose medium were assessed 
for glycolytic function via the Agilent-Seahorse Glyco TM stress test once cells 
achieved 100% confluency. The Glyco Stress test protocol was used, and the 
extracellular acidification rates (ECAR) were then recorded using the Seahorse Xfp 
analyzer (Agilent Technologies). Glycolytic capacity was calculated as (maximum 
rate measurement after oligomycin injection) – (last rate measurement before glucose 























































Figure 11. Glycolytic Reserve for LLC-PK1 cells grown in 5 mM and 17.5 mM 
glucose. Cells cultured in 5 mM glucose or 17.5 mM glucose medium were assessed 
for glycolytic function via the Agilent-Seahorse Glyco TM stress test once cells 
achieved 100% confluency and the Glyco Stress test protocol was used. The 
extracellular acidification rates (ECAR) were then recorded using the Seahorse Xfp 
analyzer (Agilent Technologies). Glycolytic reserve was calculated as (glycolytic 
capacity) – (glycolysis). Statistical significance was determined using Student’s 
















































Reducing the glucose concentration from 17.5 mM to 5 mM did not 
significantly alter mitochondrial function. Thus, media modulation was utilized to 
stimulate an increase in mitochondrial function. Additional substrates were added to 
either 2 mM or 5 mM glucose complemented media. LLC PK1 cells were cultured in 
either 5 mM (5G) or 2 mM (2G) glucose culture medium in the presence of 15 µM 
quercetin (5G15Q or 2G15Q), 5 mM acetoacetate (5G5A or 2G5A), both (2G5A15Q 
or 5G5A15Q) or without quercetin or acetoacetate. Mitochondrial assessment was 
determined via the Agilent-Seahorse Mito TM Stress Test and the oxygen consumption 
rates (OCR) were then recorded using the Seahorse Xfp analyze. 
 There were no differences in basal respiration (figure 12) or ATP-linked 
respiration (figure 13). However, there was a significant increase in maximal 
respiration (figure 14) and spare respiratory capacity (figure 15) in the 5G5A, and the 
5G5A15Q group when compared to the control group, 5 mM glucose (5G). Maximal 
respiration for 5G5A (84.2 ± 9.0 pmol O2/ min/ug DNA) and the 5G5A15Q (88.5 ± 
11.0 pmol O2/ min/ug DNA) was 45% and 53% higher respectively when compared 




















Figure 12. Basal respiration for LLC-PK1 cells grown in media complemented 
with different glucose levels and different substrates. LLC-PK1 cells were seeded 
into an 8 well extracellular flux mini culture plate at a density of 8×104 cells/well. 
The cells were cultured in either 5 mM (5G) or 2 mM (2G) glucose culture medium in 
the presence of 15 µM quercetin (5G15Q or 2G15Q), 5 mM acetoacetate (5G5A or 
2G5A), both (5G5A15Q or 2G5A15Q) or without quercetin or acetoacetate for 48 
hours to achieve confluency. The Agilent-Seahorse Mito Stress test protocol was then 
used, and the oxygen consumption rates (OCR) were then recorded using the 
Seahorse Xfp analyzer. Basal respiration was calculated as the (last rate measurement 
before oligomycin) - (non-mitochondrial respiration). Statistical significance was 
determined using one-way ANOVA, Dunnett’s multiple comparison post hoc analysis 























Figure 13. ATP-linked respiration for LLC-PK1 cells grown in media 
complemented with different glucose levels and different substrates. LLC-PK1 
cells were seeded into an 8 well extracellular flux mini culture plate at a density of 
8×104 cells/well. The cells were cultured in either 5 mM (5G) or 2 mM (2G) glucose 
culture medium in the presence of 15 µM quercetin (5G15Q or 2G15Q), 5 mM 
acetoacetate (5G5A or 2G5A), both (5G5A15Q or 2G5A15Q) or without quercetin or 
acetoacetate for 48 hours to achieve confluency and the Agilent-Seahorse Mito Stress 
test protocol was then used. The oxygen consumption rates (OCR) were then 
recorded using the Seahorse Xfp. ATP-linked respiration was calculated as (last rate 
measurement before oligomycin injection)- (minimum rate measurement after 
oligomycin injection). Statistical significance was determined using one-way 




























Figure 14. Maximal respiration for LLC-PK1 cells grown in media 
complemented with different glucose levels and different substrates. LLC-PK1 
cells were seeded into an 8 well extracellular flux mini culture plate at a density of 
8×104 cells/well. The cells were cultured in either 5 mM (5G) or 2 mM (2G) glucose 
culture medium in the presence of 15 µM quercetin (5G15Q or 2G15Q), 5 mM 
acetoacetate (5G5A or 2G5A), both (5G5A15Q or 2G5A15Q) or without quercetin or 
acetoacetate for 48 hours to achieve confluency. The Agilent-Seahorse Mito Stress 
test protocol was then used, and the oxygen consumption rates (OCR) were then 
recorded using the Seahorse Xfp. Maximal respiration was calculated as (maximum 
rate measurement after FCCP injection) - (non-mitochondrial respiration). Statistical 
significance was determined using one-way ANOVA, Dunnett’s multiple comparison 





























Figure 15. Spare respiratory capacity for LLC-PK1 cells grown in media 
complemented with different glucose levels and different substrates. LLC-PK1 
cells were seeded into an 8 well extracellular flux mini culture plate at a density of 
8×104 cells/well. The cells were cultured in either 5 mM (5G) or 2 mM (2G) glucose 
culture medium in the presence of 15 µM quercetin (5G15Q or 2G15Q), 5 mM 
acetoacetate (5G5A or 2G5A), both (5G5A15Q or 2G5A15Q) or without quercetin or 
acetoacetate for 48 hours to achieve confluency. The Agilent-Seahorse Mito Stress 
test protocol was then used, and the oxygen consumption rates (OCR) were then 
recorded using the Seahorse Xfp analyzer. Spare respiratory capacity was calculated 
as (maximal respiration) - (basal respiration). Statistical significance was determined 
using one-way ANOVA, Dunnett’s multiple comparison post hoc analysis of seven 





















Quercetin had no effect on mitochondrial function. Thus, we decided to 
examine whether the presence of 5 mM acetoacetate in culture medium will increase 
mitochondrial function. LLC-PK1 cells were cultured in 5 mM glucose (5G) or 5 mM 
glucose and 5 mM acetoacetate (5G5A).  Mitochondrial function was assessed via the 
Mito TM stress test. Cells in the acetoacetate complemented medium showed a 45% 
increase in basal respiration (29.5 ±4.1 pmol/min/ugDNA) when compared to 5G 
(20.2 ±1.9 pmol/min/ugDNA) (Figure 16). There was also a 63% increase in ATP 
linked respiration (24.7 ± 3.9 pmol/min/ugDNA) when compared to the 5G group 
(15.2 ± 1.7 pmol/min/ugDNA) (Figure 17). Maximal respiration increased by 110% 
(93.2 ± 11 pmol/min/ugDNA) in the 5G5A when compared to 5G (44.2 ± 4.2 
pmol/min/ugDNA) (Figure 18). LLC PK1 cells in 5G5A showed a 165% increase in 
spare respiratory capacity (63.7 ±7.9 pmol/min/ugDNA) when compared to cells in 
5G group (24.1 ±2.3 pmol/min/ugDNA) (Figure 19). The results demonstrated that 
acetoacetate complemented medium produced a significant increase in the measured 
mitochondrial function. 
Under conditions which increase mitochondrial function, the cells were also 
assessed for changes in glycolytic function. Cells were cultured in 5 mM glucose 
(5G) or 5 mM glucose + 5 mM acetoacetate (5G5A) complemented medium. 
Glycolytic function was determined via the Seahorse Glyco TM stress test once cells 
achieved 100% confluency. Although there is a trend, acetoacetate did not 
significantly lower glycolysis in the presence of high glucose concentration (figure 






5G5A medium (5G5A:17.2 ± 1.3 mpH/min/ugDNA, 5G: 22.8 ± 2. 
mpH/min/ugDNA) (figure 21). 
 There was also a 30% reduction in glycolytic reserve of cells in the 5G5A 
medium (5G5A: 5.44± 0.2 mpH/min/ugDNA, 5G:7.73 ± 0.58 mpH/min/ugDNA) 































Figure 16. Basal respiration for LLC-PK1 cells grown in 5 mM acetoacetate. 
LLC-PK1 cells were seeded into an 8 well extracellular flux mini culture plate at a 
density of 8×104 cells/well. The cells were cultured in either 5 mM glucose (5G) or 5 
mM glucose + 5 mM acetoacetate (5G5A) for 48 hours to achieve confluency. The 
Agilent-Seahorse Mito Stress test protocol was then used, and the oxygen 
consumption rates (OCR) were then recorded using the Seahorse Xfp analyzer.  Basal 
respiration was calculated as the (last rate measurement before oligomycin) - (non-
mitochondrial respiration). Statistical significance was determined using Student’s 



































































Figure 17. ATP-linked respiration for LLC-PK1 cells grown in 5 mM 
acetoacetate. LLC-PK1 cells were seeded into an 8 well extracellular flux mini 
culture plate at a density of 8×104 cells/well. The cells were cultured in either 5 mM 
glucose (5G) or 5 mM glucose + 5 mM acetoacetate (5G5A) for 48 hours to achieve 
confluency and the Agilent-Seahorse Mito Stress test protocol was then used. The 
oxygen consumption rates (OCR) were then recorded using the Seahorse Xfp 
analyzer.  ATP-linked respiration was calculated as (last rate measurement before 
oligomycin injection)- (minimum rate measurement after oligomycin injection). 














































































Figure 18. Maximal respiration for LLC-PK1 cells grown in 5 mM acetoacetate. 
LLC-PK1 cells were seeded into an 8 well extracellular flux mini culture plate at a 
density of 8×104 cells/well. The cells were cultured in either 5 mM glucose (5G) or 5 
mM glucose + 5 mM acetoacetate (5G5A) for 48 hours to achieve confluency and the 
Agilent-Seahorse Mito Stress test protocol was then used. The oxygen consumption 
rates (OCR) were then recorded using the Seahorse Xfp analyzer.  Maximal 
respiration was calculated as maximum rate measurement after FCCP injection) - 
(non-mitochondrial respiration). Statistical significance was determined using 








































































Figure 19. Spare respiratory capacity for LLC-PK1 cells grown in 5 mM 
acetoacetate. LLC-PK1 cells were seeded into an 8 well extracellular flux mini  
culture plate at a density of 8×104 cells/well. The cells were cultured in either 5 mM 
glucose (5G) or 5 mM glucose + 5 mM acetoacetate (5G5A) for 48 hours to achieve 
confluency. The Agilent-Seahorse Mito Stress test protocol was then used, and the 
oxygen consumption rates (OCR) were then recorded using the Seahorse Xfp 
analyzer. Spare respiratory capacity was calculated as (maximal respiration) - (basal 
respiration). Statistical significance was determined using Student’s unpaired t-test of 




























































Figure 20. Glycolysis for LLC-PK1 cells grown in 5 mM acetoacetate. Cells 
cultured in 5 mM glucose (5G) or 5 mM glucose + 5 mM acetoacetate (5G5A) 
medium were assessed for glycolytic function via the Agilent-Seahorse Glyco TM 
stress test once cells achieved 100% confluency and the Glyco Stress test protocol 
was used. The extracellular acidification rates (ECAR) were then recorded using the 
Seahorse Xfp analyzer (Agilent Technologies). Glycolysis is calculated as (maximum 
rate measurement before oligomycin injection) - (Minimum rate measurement before 
glucose injection).  Statistical significance was determined using Student’s unpaired 





































Figure 21. Glycolytic Capacity for LLC-PK1 cells grown in 5 mM acetoacetate. 
Cells cultured in 5 mM glucose(5G) or 5 mM glucose + 5 mM acetoacetate (5G5A) 
medium were assessed for glycolytic function via the Agilent-Seahorse Glyco TM 
stress test once cells achieved 100% confluency and the Glyco Stress test protocol 
was used. The extracellular acidification rates (ECAR) were then recorded using the 
Seahorse Xfp analyzer (Agilent Technologies). Glycolytic capacity is (maximum rate 
measurement after oligomycin injection) – (last rate measurement before glucose 
injection). Statistical significance was determined using Student’s unpaired t-test of 















































































Figure 22. Glycolytic Reserve for LLC-PK1 cells grown in 5 mM acetoacetate. 
Cells cultured in 5 mM glucose (5G) or 5 mM glucose + 5 mM acetoacetate (5G5A) 
medium were assessed for glycolytic function via the Agilent-Seahorse Glyco TM 
stress test once cells achieved 100% confluency and the Glyco Stress test protocol 
was used. The extracellular acidification rates (ECAR) were then recorded using the 
Seahorse Xfp analyzer (Agilent Technologies). Glycolytic reserve was calculated as 
(Glycolytic capacity) – (Glycolysis). Statistical significance was determined using 





































































Acetoacetate stimulated an increase in measured mitochondrial parameters, 
with a decrease in glycolytic capacity and glycolytic reserve. To determine if 
acetoacetate complemented media increases mitochondrial content, lysates of cells 
(20×106 cells) cultured in 5G or 5G5A media were assessed for citrate synthase 
activity, a marker of mitochondrial function and content (Larsen et al. 2012). There 
was a 44% increase in citrate synthase activity (figure 23) in cells cultured in the 
5G5A medium (5G: 10.0 ± 0.78 nmol/min/mg protein, 5G5A: 14.4 ± 0.20 
nmol/min/mg protein). This indicates that there is an increase in mitochondrial 
function and content.  
To further determine mitochondrial content, biomarkers of mitochondrial 
biogenesis, PGC-1α (peroxisome-proliferator-activated receptor γ co-activator-1α) 
and TFAM (mitochondrial transcription factor A) were assessed in addition to 
mitochondrial protein COX IV. Acetoacetate complemented medium stimulated a 
2.91-fold change in PGC-1α expression when compared to 5G (figure 24). There was 
a 2.41-fold change in TFAM (figure 25) and a 9.81-fold change in COX IV 
expression (figure 26) for cells cultured in 5G5A complemented medium. These 
results suggest that acetoacetate complemented media stimulated an increase in 




























Figure 23. Citrate Synthase activity for LLC-PK1 cells grown in 5 mM 
acetoacetate. Cells cultured in 5 mM glucose (5G) or 5 mM glucose + 5 mM 
acetoacetate (5G5A) medium were lysed in RIPA buffer 100% confluency is 
achieved. Cells were then lysed using RIPA buffer and 5µL of lysates containing 5 µg 
of sample was used for the assay. Specific activity of citrate synthase (umols/min/mg) 
was determined via a plate based colorimetric measurement in accordance with the 
Cayman MitoCheck® Synthase Activity Assay kit. Statistical significance was 































































Figure 24.  Expression of PGC-1α in LLC-PK1 cells grown in 5 mM 
acetoacetate. Cells cultured in 5 mM glucose (5G) or 5 mM glucose + 5 mM 
acetoacetate (5G5A) medium were lysed in RIPA buffer 100% confluency is 
achieved. Cells were then lysed using RIPA buffer. Samples, at a concentration of 1 
mg/ml were subjected to capillary electrophoresis followed by immunodetection. 
Expression of PGC-1α was normalized to expression of GAPDH. Statistical 














































Figure 25.  Expression of TFAM in LLC-PK1 cells grown in 5 mM acetoacetate. 
Cells cultured in 5 mM glucose (5G) or 5 mM glucose + 5 mM acetoacetate (5G5A) 
medium were lysed in RIPA buffer 100% confluency is achieved. Cells were then 
lysed using RIPA buffer. Samples, at a concentration of 1 mg/ml were subjected to 
capillary electrophoresis followed by immunodetection. Expression of TFAM was 
normalized to expression of GAPDH. Statistical significance was determined using 














































Figure 26.  Expression of COX IV in LLC-PK1 cells grown in 5 mM 
acetoacetate. Cells cultured in 5 mM glucose (5G) or 5 mM glucose + 5 mM 
acetoacetate (5G5A) medium were lysed in RIPA buffer 100% confluency is 
achieved. Cells were then lysed using RIPA buffer. Samples, at a concentration of 1 
mg/ml were subjected to capillary electrophoresis followed by immunodetection. 
Expression of COX IV was normalized to expression of GAPDH. Statistical 



























Acetoacetate stimulated an increase in mitochondrial function and content. 
This increase may stimulate an increased sensitivity to mitochondrial toxicants. To 
examine if acetoacetate alters the LC50 value (table 1) of mitochondrial toxicants, a 
viability assay was conducted for 24 hours and viability assessed via a modified 
trypan blue assay (Hammoudeh et al. 2019). Cells cultured in 5G5A demonstrated a 
36% decline in the LC50 value (713 ± 12 µM) when treated with diclofenac, a non-
steroidal anti-inflammatory drug (NSAID), in comparison to 5G group (1112 ± 47 
µM) (table 1). There was also a 19% decrease in the LC50 value (25.4 ± 0.95 µM) for 
cells cultured in 5G5A when treated with clotrimazole (antifungal agent), when 
compared to the LC50 value for 5G (31.2 ± 1.5 µM) (table 1). However, there were no 
significant differences in the LC50 values when cells in both media conditions were 
treated with ciprofibrate (anti-lipidemic agent) (table 1). 
To assess if acetoacetate stimulates an increased response to mitochondrial 
toxicants, the Seahorse Mito TM stress test was conducted, and cells were exposed to 
the previously determined LC50 values of the mitochondrial toxicants. Diclofenac 
stimulated a 128% increase in OCR (Figure 27) for cells cultured in 5G5A (81.9 ± 6.1 
pmol/min/µg DNA) when compared cells cultured in 5G only (36.0 ± 2.0 
pmol/min/µg DNA). The increase in OCR post oligomycin was unaffected by the 
addition of FCCP, a known uncoupler, in both 5G and 5G5. This suggests that 
diclofenac acts an uncoupler. There was a significant decrease in OCR for both 
clotrimazole and ciprofibrate for cells in the 5G5A medium. Clotrimazole caused a 
66% decline in OCR (figure 28) for cells cultured in 5G5A (56 ± 3.5 pmol/min/μg 






Ciprofibrate treatment resulted in a 129% decrease in OCR (figure 29) for cells 
cultured in 5G5A (74.0 ± 3.7 pmol/min/µg DNA), when compared to the 5G group 
(32.3 ± 3.8 pmol/min/µg DNA). These compounds demonstrated a stronger inhibitory 
effect on the ETC (electron transport) chain in the 5G5A group. These findings 
indicate that acetoacetate complemented media can sensitize cells to mitochondrial 





























Table 5.  LC50 value for mitochondrial toxicants in LLC-PK1 cells grown in 5 
mM acetoacetate. Cells cultured in 5 mM glucose (5G) or 5 mM glucose + 5 mM 
acetoacetate (5G5A) medium were seeded in 96 well plates at a density of 15 X 103 
cells/well and allowed to grow until confluent monolayers were formed. Cells were 
then treated for 24 hours with increasing concentrations of diclofenac (0.5 - 5mM), 
clotrimazole (0.1 – 100 µM) and ciprofibrate (1 - 40 µM). Cell viability measured 
using a modified trypan blue-based viability assessment (Hammoudeh et al. 2019). 

















































Compound LC50 value 5G LC50 value 5G5A 
Diclofenac 1112± 46.98 μM 713 ± 11.99 μM * 
Clotrimazole 31.18 ± 1.47 μM 25.41 ± 0.95 μM * 

















Figure 27.  Acute response of LLC-PK1 cells to the LC 50 value of Diclofenac.  
LLC-PK1 cells were seeded into an 8 well extracellular flux mini culture plate at a 
density of 8×104 cells/well. The cells were cultured in either 5 mM glucose (5G) or 5 
mM glucose + 5 mM acetoacetate (5G5A) for 48 hours to achieve confluency and a 
modified Agilent-Seahorse Mito Stress test protocol was used. Cells were exposed to 
1μM Oligomycin, followed by the previously determined LC50 value of diclofenac for 
5G (1112 µM) or 5G5A (713.3µM). This was then followed by 1μM of FCCP and 
finally a mixture of rotenone and antimycin A at 0.5 μM. The oxygen consumption 
rates (OCR) were then recorded using the Seahorse Xfp analyzer. Maximal 
respiration was calculated as maximum rate measurement after FCCP injection) - 
(non-mitochondrial respiration). Statistical significance was determined using 






















































































































































Figure 28.  Acute response of LLC-PK1 cells to the LC 50 value of Clotrimazole.  
LLC-PK1 cells were seeded into an 8 well extracellular flux mini culture plate at a 
density of 8×104 cells/well. The cells were cultured in either 5 mM glucose (5G) or 5 
mM glucose + 5 mM acetoacetate (5G5A) for 48 hours to achieve confluency and the 
Agilent-Seahorse Mito Stress test protocol was then used. The oxygen consumption 
rates (OCR) were then recorded using the Seahorse Xfp analyzer.  Cells were exposed 
to the LC50 value of clotrimazole for 5G (31.2µM) or 5G5A (25.4 µM). Decrease in 
Oxygen consumption rate (OCR) was calculated by subtracting maximal OCR post 
FCCP – lowest OCR post clotrimazole. Statistical significance was determined using 














































































































































Figure 29.  Acute response of LLC-PK1 cells to the LC 50 value of Ciprofibrate.  
LLC-PK1 cells were seeded into an 8 well extracellular flux mini culture plate at a 
density of 8×104 cells/well. The cells were cultured in either 5 mM glucose (5G) or 5 
mM glucose + 5 mM acetoacetate (5G5A) for 48 hours to achieve confluency and the 
Agilent-Seahorse Mito Stress test protocol was then used. The oxygen consumption 
rates (OCR) were then recorded using the Seahorse Xfp analyzer.  Cells were exposed 
to the LC50 value of ciprofibrate for 5G (18.3 µM) and 5G5A (26.1µM). Decrease in 
Oxygen consumption rate (OCR) was calculated by subtracting maximal OCR post 
FCCP – lowest OCR post clotrimazole. Statistical significance was determined using 







































































































































The results of this study have demonstrated that culture media complemented 
with acetoacetate, can induce a change in the bioenergetic profile of LLC-PK1 cells, 
resulting in a cell line with increased sensitivity to mitochondrial toxicants. Lowering 
the glucose concentration from 17.5 mM to 5 mM, did not alter the mitochondrial 
function (figure 5- figure 8). A reduced glucose concentration also failed to reduce 
glycolytic function (figure 9-figure 11). Quercetin did not alter mitochondrial 
function. Although previously mentioned studies indicated that quercetin can increase 
mitochondrial function, that was not observed in our study. Quercetin inhibited cell 
proliferation in human breast carcinoma SK-Br3 cells, in a dose dependent manner (1 
µM to 10 µM) (Jeong et al. 2009). Quercetin did not impact cell proliferation for 
LLC-PK1 cells at 15 µM, however, the impact of quercetin on mitochondrial function 
has not yet been determined and will be evaluated in future studies. Extracellular flux 
analysis demonstrated that acetoacetate stimulated an increase in mitochondrial 
function, accompanied by a decrease in glycolytic capacity and reserve.  
Additionally, acetoacetate stimulated an increase in citrate synthase activity, 
as well as an increase in PGC-1α, TFAM and COX IV protein expression. This 
indicates that this cell line was genetically reprogrammed by the presence of 
acetoacetate in the culture media.  It is well known the acetoacetate can be utilized as 
a source of fuel. Additionally, acetoacetate as well as betahydroxybutyrate can 
participate in signaling pathways that result in a change in metabolic activity 
(Grabacka et al. 2016). Therefore, this ketone body can affect mitochondrial and 






Acetoacetate stimulated an increase in basal respiration. Basal respiration is 
the baseline oxygen consumption that is controlled by ATP turnover, substrate 
oxidation and proton leak. Basal respiration is sensitive to changes in ATP demand or 
the presence of different substrates (Brand and Nicholls 2011). The addition and 
oxidation of fatty acids and pyruvate can greatly increase the basal respiration rates of 
hepatocytes (Brand and Nicholls 2011). Likewise, the addition of acetoacetate 
stimulated an increase in LLC-PK1 cells.  ATP turnover is the ratio between ATP 
production and ATP content. (Brand and Nicholls 2011). Increase in ATP utilization 
will affect ATP content and stimulate and increase in ATP production. This will then 
increase basal respiration. ATP linked respiration can be described as the rate of 
mitochondrial ATP synthesis in a basal state (Brand and Nicholls 2011). Substrate 
oxidation can influence ATP turnover, resulting in an increase in ATP production. As 
a result, ATP linked respiration was significantly increased in the acetoacetate group.  
Uncoupled respiration (maximal respiration) was significantly higher in cells 
that were cultured in the presence of acetoacetate. The rate of respiration is controlled 
by two factors, the mitochondrial proton circuit and the thermodynamic 
disequilibrium. In the mitochondrial proton circuit, proton extrusion balances proton 
reentry under steady state conditions (Brand and Nicholls 2011). Additionally, the 
rate of respiration also requires a thermodynamic disequilibrium, where the free 
energy required for electron transfer must be greater than energy required to pump 
protons across the membrane against the protonmotive force (PMF) (Brand and 
Nicholls 2011).  This disequilibrium is necessary for the forward movement of 






respiration by inducing an artificial proton permeability in the mitochondrial 
membrane. This lowers PMF and increases the thermodynamic disequilibrium, which 
is a factor that controls respiration (Brand and Nicholls 2011).  As a result, the proton 
current and respiration increases. Reduced or low maximal respiration values can 
indicate mitochondrial dysfunction. The significant increase in maximal respiration 
indicates a significant increase in spare respiratory capacity, which is the difference 
between maximal and basal respiration. 
The spare respiratory capacity is the ability of the substrate supply and 
electron transport to respond to an increase in energetic demand (Brand and Nicholls 
2011). An energetic demand is created when an energy pathway is inhibited and the 
cells must rely on another pathway to maintain ATP content. A reduced or small 
respiratory capacity can indicate mitochondrial dysfunction that is often not apparent 
under basal or baseline cellular conditions (Brand and Nicholls 2011).  Thus, it can be 
safely assumed that the addition of acetoacetate had a significant effect on 
mitochondrial activity.  
The results of this study indicate that acetoacetate complemented media, 
increased PGC-1α expression which resulted in an increase in mitochondrial content. 
PGC-1α [PPAR (peroxisome proliferator-activated receptor)-γ coactivator-1α] is 
often viewed as a master regulator of mitochondrial biogenesis (Jornayvaz and 
Shulman 2010). An increase in PGC-1α mRNA expression in skeletal muscle and 
brown fat, was accompanied by an increased expression of mitochondrial proteins 
namely ATP synthase (β subunit) and Cytochrome c oxidase (COXIV) subunits 






transcription factors nuclear respiratory factors 1 and 2 (NRF1 and NRF2) which 
stimulate expression of mitochondrial transcription factor A (TFAM) (Jornayvaz and 
Shulman 2010). NRF-1 and 2 are activated downstream of PGC1α where they 
regulate genes associated with mitochondrial respiration (Scarpulla, 2011). NRF-1 
targets are genes that encode the subunits of the five complexes (Scarpulla 2006).  
NRF-1 also increases the expression of human genes encoding constituents of the 
mtDNA transcription machinery which are nuclear encoded factors that control 
mitochondrial gene expression (Scarpulla 2006).  
They include TFAM, TFB1M, TFB2M (transcription specificity factors B1 
and B2 mitochondrial), and POLRMT (mitochondrial RNA polymerase) (Scarpulla, 
2006).  NRF-1 binds to the promoter regions of TFAM and TFB1M and TFB2M, 
increasing mitochondrial transcription (Scarpulla, 2008). Additionally, NRF-2 also 
binds to the above-mentioned transcription factors as well as the cis elements in the 
promoter region of COXIV (Scarpulla 2008).  
Based on the results, acetoacetate can stimulate increase in mitochondrial 
content in a PGC-1α mediated manner, resulting in an increased protein expression of 
TFAM and COX IV. This was further supported by an increase in citrate synthase 
activity (Figure 19). Transmission electron microscopy of skeletal muscle revealed a 
strong correlation between mitochondrial fractional area and citrate synthase activity 
(Larsen et al. 2012). Despite these findings, the exact signaling pathway by which 
acetoacetate stimulates an increase in function and content in not yet known. 






energy demands of transporting epithelia such as proximal tubular cells (Cotter et 
al.2013).  
Acetoacetate undergoes ketolysis, which is the oxidation of acetoacetate to yield 
acetyl CoA during times of starvation and increased energy demand (Gabacka et al. 
2016).  It is a pathway that take place in the mitochondria of most cells except 
hepatocytes and most malignantly transformed cells (Grabacka et al. 2016). LLC PK1 
cells are non-malignantly transformed and can utilize acetoacetate in this manner.  
Oxidation of acetoacetate which yields two molecules of acetyl CoA can 
result in an increase in citrate levels that can potentially impact glycolytic activity. 
Citrate inhibits phosphofructokinase, the regulatory enzyme of glycolysis (Usenik and 
Legisa, 2010). Results of this study demonstrate a reduction in glycolytic capacity as 
well as glycolytic reserve. Glycolytic capacity is a measure of the cell’s maximum 
conversion rate of glucose to pyruvate or lactate (Mookerjee et al. 2016).  It is a 
measure of the maximum capacity to generate ATP via glycolysis given that 
glycolytic ATP synthesis is linked to glycolytic carbon flux (Mookerjee et al. 2016). 
This maximum increase is measured in the presence of added glucose, and 
oligomycin, which inhibits ATP synthase. A reduced glycolytic capacity 
demonstrates a limited glycolytic machinery (Mookerjee et al. 2016).  
Glycolytic reserve indicates how well the cell can respond to an energetic 
demand using glycolysis. This parameter was significantly lower for cells grown in 
the presence of acetoacetate, suggesting that their ability to utilize glycolysis is 
reduced. The exact mechanism that illustrates the effect acetoacetate has on the 







 The results of this study indicate that acetoacetate has reprogrammed the 
LLC-PK1 cell line in PGC-1α mediated manner. However, the exact mechanism has 
not been examined in this study. A possible mechanism is the histone deacetylase 
(HDAC) inhibition pathway. HDAC are enzymes that remove an acetyl group from 
histones which are proteins that package and compact chromosomal DNA into the 
nucleus, resulting in a DNA/protein complex that is chromatin (Mihaylova and Shaw, 
2013). In this form, DNA is less accessible to transcription factors. Thus, HDACs 
have a repressive effect on transcription (Mihaylova et al. 2013). HDAC inhibitors 
inhibit the action of these enzymes facilitating transcription of genes that regulate 
energy metabolism (Mihaylova et al. 2013). Betahydroxybutyrate (BHB), has been 
shown to act as a class I HDAC inhibitor (Shimazu et al. 2013). BHB stimulated 
global acetylation via inhibition of HDAC in human embryonic kidney cells (HEK 
293) when treated with BHB for 8 hours at 1, 2, and 3 mM concentrations (Shimazu 
et al. 2013).  
Additionally, HDAC inhibitors such as valproic acid have been shown to 
inhibit glucose transport and hexokinase 1 activity in the OPM2 human multiple 
myeloma cell line (Wardell et al. 2009).  Valproic acid also upregulated PGC-1α 
expression in SH-SY5Y neuroblastoma cells at 10 mM at 48hrs (Cowell et al. 2009). 
It is possible that acetoacetate acts an HDAC inhibitor, stimulating an increase in 
PGC-1α expression.  
A reduction of glycolytic capacity and reserve coupled with an increase in 






with increased sensitivity to mitochondrial toxicants. Diclofenac stimulated a 
significant increase in OCR in the acetoacetate group, indicating that this NSAID acts 
as an uncoupler (Moreno-Sanchez et al. 1999). This increased sensitivity to 
mitochondrial toxicants is due to the reduced glycolytic function combined with an 
increased reliance on oxidative phosphorylation. The cells are unable to utilize 
glycolysis sufficiently when mitochondrial function is compromised.  
 Clotrimazole and ciprofibrate have been documented as ETC inhibitors 
(Wills et al. 2015). ETC inhibitors decrease OCR. The results of this study have 
shown that the toxic effects of clotrimazole and ciprofibrate were more pronounced in 
the cells grown in the acetoacetate complemented medium. This indicates that 
acetoacetate increased the sensitivity of LLC-PK1 cells to toxicants. Although the 
LC50 value for ciprofibrate did not decrease significantly for cells grown in 
acetoacetate, there was a significant decrease in OCR for the acetoacetate group when 
treated with ciprofibrate. The results suggest that viability assays alone are not 
representative of mitochondrial toxicity. 
 In conclusion, addition of acetoacetate to culture media resulted in an 
increase in mitochondrial function and content, with a concomitant reduction in 
glycolytic capacity and reserve.  This shift in energy metabolism results in a model 
with increased sensitivity to toxicants, improving its sensitivity and reliance as a 









5. FUTURE DIRECTIONS 
Further studies will elucidate the signaling pathway that results in an increase 
in mitochondrial function and content. Assessment of HDAC activity can elucidate 
the impact of acetoacetate on PGC-1α expression. HDAC inhibition will result in 
increased acetylation of histone proteins (Shimazu et al. 2013). Analysis of acetylated 
histone levels in the presence of acetoacetate can elucidate a potential mechanism that 
stimulates an increase in mitochondrial biogenesis.  
It is necessary to compare the improved sensitivity of LLC-PK1 cells with 
other routinely used cell lines such as HK-2, HEK 293 and the primary proximal 
tubular cultures. Comparative viability assays will determine if acetoacetate confers 
greater sensitivity to LLC-PK1 cells than the immortalized human cell lines and the 
primary counterparts. Additionally, future studies will determine if acetoacetate 
complemented media can reprogram the above-mentioned immortalized cell lines by 
stimulating an increase in mitochondrial function with a concomitant increase in 
sensitivity to mitochondrial toxicants. 
The purpose of this study was to improve renal culture cells for in vitro 
toxicity testing. It is necessary to examine the efficacy of acetoacetate complemented 
media in a high throughput screening platform. This will facilitate screening of 
multiple pharmacologically relevant compounds for nephrotoxicity and will 










Media Composition: SFFD (DMEM: Ham’s F-12) 
COMPONENTS MW SFFD   
Catalog number       
Amino Acids   mg/L mM 
Glycine 75 18.75 0.25 
L-Alanine 89 4.45 0.05 
L-Arginine hydrochloride 211 147.5 0.699 
L-Asparagine-H2O 150 7.5 0.05 
L-Aspartic acid 133 6.65 0.05 
L-Cysteine hydrochloride-H2O 176 17.56 0.0998 
L-Cystine 2HCl 313 31.29 0.1 
L-Glutamic Acid 147 7.35 0.05 
L-Glutamine 146 365 2.5 
L-Histidine hydrochloride-H2O 210 31.48 0.15 
L-Isoleucine 131 54.47 0.416 
L-Leucine 131 59.05 0.451 
L-Lysine hydrochloride 183 91.25 0.499 
L-Methionine 149 17.24 0.116 
L-Phenylalanine 165 35.48 0.215 
L-Proline 115 17.25 0.15 
L-Serine 105 26.25 0.25 
L-Threonine 119 53.45 0.449 
L-Tryptophan 204 9.02 0.0442 
L-Tyrosine   181     
L-Tyrosine disodium salt dihydrate 261 55.79 0.214 
















COMPONENTS MW SFFD  
Vitamins  mg/mL   
Biotin 244 0.0035 0.0000143 
Choline chloride 140 8.98 0.0641 
D-Calcium pantothenate 477 2.24 0.0047 
Folic Acid 441 2.65 0.00601 
i-Inositol 180 12.6 0.07 
Niacinamide 122 2.02 0.0166 
Pyridoxine hydrochloride 206 2 0.00971 
Riboflavin 376 0.219 0.000582 
Thiamine hydrochloride 337 2.17 0.00644 






















Inorganic Salts                                     MW  Mg/mL  mM 
Calcium Chloride (CaCl2) (anhyd.) 111 116.6 1.05 
Cupric sulfate (CuSO4-5H2O) 250 0.0013 0.0000052 
Ferric Nitrate (Fe(NO3)3"9H2O) 404 0.05 0.000124 
Ferric sulfate (FeSO4-7H2O) 278 0.417 0.0015 
Magnesium Chloride (anhydrous) 95 28.64 0.301 
Magnesium Sulfate (MgSO4) (anhyd.) 120 48.84 0.407 
Potassium Chloride (KCl) 75 311.8 4.16 
Sodium Bicarbonate (NaHCO3) 84 1200 14.29 
Sodium Chloride (NaCl) 58 6995.5 120.61 
Sodium Phosphate dibasic (Na2HPO4) 
anhydrous 
142 71.02 0.5 
Sodium Phosphate monobasic 
(NaH2PO4-H2O) 
138 62.5 0.453 
















Other Components            MW  mg/mL  mM 
D-Glucose (Dextrose) 180 3151 17.51 
HEPES 238 3574.5 15.02 
Hypoxanthine Na 159 2.39 0.015 
Linoleic Acid 280 0.042 0.00015 
Lipoic Acid 206 0.105 0.00051 
Phenol Red 376.4 8.1 0.0215 
Putrescine 2HCl 161 0.081 0.000503 
Sodium Pyruvate 110 55 0.5 






Citrate Synthase Activity  
Working Reagent Preparation 
Reagent A Reagent B 
20 μL of Acetyl coA reagent 20 μL of Oxaloacetate reagent 
20 μL of Developer reagent 480 μL of Assay buffer 
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